326 related articles for article (PubMed ID: 22369132)
1. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
Shaw-Smith C; Flanagan SE; Patch AM; Grulich-Henn J; Habeb AM; Hussain K; Pomahacova R; Matyka K; Abdullah M; Hattersley AT; Ellard S
Pediatr Diabetes; 2012 Jun; 13(4):314-21. PubMed ID: 22369132
[TBL] [Abstract][Full Text] [Related]
2. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
Labay V; Raz T; Baron D; Mandel H; Williams H; Barrett T; Szargel R; McDonald L; Shalata A; Nosaka K; Gregory S; Cohen N
Nat Genet; 1999 Jul; 22(3):300-4. PubMed ID: 10391221
[TBL] [Abstract][Full Text] [Related]
3. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD
Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223
[TBL] [Abstract][Full Text] [Related]
4. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood.
Olsen BS; Hahnemann JM; Schwartz M; Østergaard E
Pediatr Diabetes; 2007 Aug; 8(4):239-41. PubMed ID: 17659067
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.
Raz T; Labay V; Baron D; Szargel R; Anbinder Y; Barrett T; Rabl W; Viana MB; Mandel H; Baruchel A; Cayuela JM; Cohen N
Hum Mutat; 2000; 16(1):37-42. PubMed ID: 10874303
[TBL] [Abstract][Full Text] [Related]
6. The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
Fleming JC; Tartaglini E; Steinkamp MP; Schorderet DF; Cohen N; Neufeld EJ
Nat Genet; 1999 Jul; 22(3):305-8. PubMed ID: 10391222
[TBL] [Abstract][Full Text] [Related]
7. Incidence, genetics, and clinical phenotype of permanent neonatal diabetes mellitus in northwest Saudi Arabia.
Habeb AM; Al-Magamsi MS; Eid IM; Ali MI; Hattersley AT; Hussain K; Ellard S
Pediatr Diabetes; 2012 Sep; 13(6):499-505. PubMed ID: 22060631
[TBL] [Abstract][Full Text] [Related]
8. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
Onal H; Bariş S; Ozdil M; Yeşil G; Altun G; Ozyilmaz I; Aydin A; Celkan T
Turk J Pediatr; 2009; 51(3):301-4. PubMed ID: 19817279
[TBL] [Abstract][Full Text] [Related]
9. Leber's congenital amaurosis as the retinal degenerative phenotype in thiamine responsive megaloblastic anemia: a case report.
Srikrupa NN; Meenakshi S; Arokiasamy T; Murali K; Soumittra N
Ophthalmic Genet; 2014 Jun; 35(2):119-24. PubMed ID: 23638917
[TBL] [Abstract][Full Text] [Related]
10. Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
Ricketts CJ; Minton JA; Samuel J; Ariyawansa I; Wales JK; Lo IF; Barrett TG
Acta Paediatr; 2006 Jan; 95(1):99-104. PubMed ID: 16373304
[TBL] [Abstract][Full Text] [Related]
11. Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.
Ghaemi N; Ghahraman M; Abbaszadegan MR; Baradaran-Heravi A; Vakili R
J Clin Res Pediatr Endocrinol; 2013 Sep; 5(3):199-201. PubMed ID: 24072090
[TBL] [Abstract][Full Text] [Related]
12. First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
Pomahačová R; Zamboryová J; Sýkora J; Paterová P; Fiklík K; Votava T; Černá Z; Jehlička P; Lád V; Šubrt I; Dort J; Dortová E
Pediatr Diabetes; 2017 Dec; 18(8):844-847. PubMed ID: 28004468
[TBL] [Abstract][Full Text] [Related]
13. Thiamine responsive megaloblastic anemia: a novel SLC19A2 compound heterozygous mutation in two siblings.
Mozzillo E; Melis D; Falco M; Fattorusso V; Taurisano R; Flanagan SE; Ellard S; Franzese A
Pediatr Diabetes; 2013 Aug; 14(5):384-7. PubMed ID: 23289844
[TBL] [Abstract][Full Text] [Related]
14. Thiamine-responsive megaloblastic anemia syndrome with atrial standstill: a case report.
Aycan Z; Baş VN; Cetinkaya S; Ağladioğlu SY; Kendirci HN; Senocak F
J Pediatr Hematol Oncol; 2011 Mar; 33(2):144-7. PubMed ID: 21285901
[TBL] [Abstract][Full Text] [Related]
15. Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
Mikstiene V; Songailiene J; Byckova J; Rutkauskiene G; Jasinskiene E; Verkauskiene R; Lesinskas E; Utkus A
Am J Med Genet A; 2015 Jul; 167(7):1605-9. PubMed ID: 25707023
[TBL] [Abstract][Full Text] [Related]
16. Thiamine responsive megaloblastic anemia: the puzzling phenotype.
Beshlawi I; Al Zadjali S; Bashir W; Elshinawy M; Alrawas A; Wali Y
Pediatr Blood Cancer; 2014 Mar; 61(3):528-31. PubMed ID: 24249281
[TBL] [Abstract][Full Text] [Related]
17. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
Li X; Cheng Q; Ding Y; Li Q; Yao R; Wang J; Wang X
BMC Pediatr; 2019 Jul; 19(1):233. PubMed ID: 31296181
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
Zhang S; Qiao Y; Wang Z; Zhuang J; Sun Y; Shang X; Li G
Clin Chim Acta; 2021 May; 516():157-168. PubMed ID: 33571483
[TBL] [Abstract][Full Text] [Related]
19. Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome.
Lagarde WH; Underwood LE; Moats-Staats BM; Calikoglu AS
Am J Med Genet A; 2004 Mar; 125A(3):299-305. PubMed ID: 14994241
[TBL] [Abstract][Full Text] [Related]
20. Thiamine-responsive megaloblastic anemia syndrome (TRMA) with cone-rod dystrophy.
Meire FM; Van Genderen MM ; Lemmens K; Ens-Dokkum MH
Ophthalmic Genet; 2000 Dec; 21(4):243-50. PubMed ID: 11135496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
